(R)-3-(((7-((4-Isopropylphenyl)(methyl)amino)chroman-4-yl)methyl)amino)isonicotinic acid

Catalog No. :
ACNRDG365
CAS No. :
1851412-93-5
Molecular Formula :
C26H29N3O3
Molecular Weight :
431.54

IUPAC Name:(R)-3-(((7-((4-isopropylphenyl)(methyl)amino)chroman-4-yl)methyl)amino)isonicotinic acid

(R)-3-(((7-((4-Isopropylphenyl)(methyl)amino)chroman-4-yl)methyl)amino)isonicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$114.00Login to see priceInquiryInquiry
5mg98%$282.00Login to see priceInquiryInquiry
10mg98%$470.00Login to see priceInquiryInquiry
25mg98%$754.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-(((7-((4-Isopropylphenyl)(methyl)amino)chroman-4-yl)methyl)amino)isonicotinic acid
IUPAC Name(R)-3-(((7-((4-isopropylphenyl)(methyl)amino)chroman-4-yl)methyl)amino)isonicotinic acid
Molecular FormulaC26H29N3O3
Molecular Weight431.54
SMILESO=C(O)C1=CC=NC=C1NC[C@@H]2CCOC3=C2C=CC(N(C4=CC=C(C(C)C)C=C4)C)=C3
InChI KeyNDVITLLKZQXKGU-IBGZPJMESA-N
Synonym4-Pyridinecarboxylic acid, 3-[[[(4R)-3,4-dihydro-7-[methyl[4-(1-methylethyl)phenyl]amino]-2H-1-benzopyran-4-yl]methyl]amino]-;Zavondemstat;Zavondemstat??(QC8222;TACH 101 free base);Zavondemstat (Synonyms: QC8222 free base;RMA-4115
CAS No.1851412-93-5

Synthetic Route by SureRoute

1. ACNRDG365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNRDG365 route product structure diagram
    ACNRDG3651851412-93-5
Inquiry

2. ACNRDG365 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDKWS138 route compound structure diagram
    ACDKWS138393-53-3 In Stock
  4. Then
  5. ACNRDG365 route product structure diagram
    ACNRDG3651851412-93-5
Inquiry

Comments (0)